ProfileGDS4718 / 1552367_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 83% 33% 79% 83% 29% 31% 81% 86% 85% 79% 81% 28% 31% 53% 64% 83% 28% 27% 24% 79% 74% 85% 84% 68% 49% 83% 16% 88% 32% 67% 19% 79% 88% 25% 41% 50% 74% 80% 25% 84% 12% 36% 23% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2914783
GSM549102patient 115, normal, homogenized [OPG study]8.1000383
GSM549104patient 119, normal, homogenized [OPG study]4.649933
GSM549108patient 138, normal, homogenized [OPG study]7.5891979
GSM549119patient 077, normal, homogenized [OPG study]8.1672483
GSM549133patient 032, cancer, homogenized [OPG study]4.4220929
GSM549139patient 042, cancer, homogenized [OPG study]4.5557231
GSM549099patient 107, normal, homogenized [OPG study]7.8652281
GSM549109patient 139, normal, homogenized [OPG study]8.6007786
GSM549110patient 046, normal, homogenized [OPG study]8.4122585
GSM549114patient 063, normal, homogenized [OPG study]7.7973979
GSM549122patient 082, normal, homogenized [OPG study]8.0007381
GSM549134patient 033, cancer, homogenized [OPG study]4.4664128
GSM549136patient 036, cancer, homogenized [OPG study]4.5258531
GSM549140patient 044, cancer, homogenized [OPG study]5.6730953
GSM549111patient 047, normal, homogenized [OPG study]6.4121564
GSM549113patient 057, normal, homogenized [OPG study]8.3927783
GSM549132patient 031, cancer, homogenized [OPG study]4.4630328
GSM549137patient 038, cancer, homogenized [OPG study]4.4156127
GSM549142patient 047, cancer, homogenized [OPG study]4.4175324
GSM549100patient 110, normal, homogenized [OPG study]7.6347579
GSM549107patient 135, normal, homogenized [OPG study]7.2518374
GSM549115patient 068, normal, homogenized [OPG study]8.6576585
GSM549116patient 072, normal, homogenized [OPG study]8.3376684
GSM549120patient 078, normal, homogenized [OPG study]6.6640868
GSM549131patient 030, cancer, homogenized [OPG study]5.3836849
GSM549118patient 074, normal, homogenized [OPG study]8.2643983
GSM549129patient 027, cancer, homogenized [OPG study]4.0094516
GSM549123patient 088, normal, homogenized [OPG study]8.9469388
GSM549124patient 006, cancer, homogenized [OPG study]4.686432
GSM549126patient 015, cancer, homogenized [OPG study]6.6484267
GSM549128patient 025, cancer, homogenized [OPG study]4.0665919
GSM549103patient 117, normal, homogenized [OPG study]7.6550279
GSM549117patient 073, normal, homogenized [OPG study]8.9945688
GSM549138patient 041, cancer, homogenized [OPG study]4.3298125
GSM549141patient 045, cancer, homogenized [OPG study]4.9651641
GSM549130patient 028, cancer, homogenized [OPG study]5.5359150
GSM549101patient 111, normal, homogenized [OPG study]7.2017274
GSM549105patient 128, normal, homogenized [OPG study]7.8470780
GSM549106patient 134, normal, homogenized [OPG study]4.2697525
GSM549112patient 048, normal, homogenized [OPG study]8.3418384
GSM549125patient 011, cancer, homogenized [OPG study]3.8434812
GSM549127patient 024, cancer, homogenized [OPG study]4.8095836
GSM549135patient 035, cancer, homogenized [OPG study]4.1985623